Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency
Clinical trial NCT03815396 · COMPLETED
Trial details
- NCT number
- NCT03815396
- Sponsor
- Inhibrx Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-19
- Primary completion
- 2022-08-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.